novel
coronaviru
associ
worldwid
outbreak
atyp
pneumonia
refer
sever
acut
respiratori
syndrom
sarscov
sarscov
nucleocapsid
n
protein
clone
sequenc
express
escherichia
coli
strain
purifi
n
protein
use
measur
sarscov
specif
igg
antibodi
sarscov
infect
patient
sera
control
subject
use
elisa
assay
specif
antibodi
respons
purifi
recombin
n
protein
day
diseas
onset
observ
sar
patient
sera
respect
comparison
detect
result
commerci
avail
diagnost
kit
coat
mixtur
sarscov
viral
protein
show
posit
respons
respect
none
control
sera
gave
posit
reaction
either
assay
data
suggest
n
protein
sarscov
immunodomin
elisa
base
test
assay
detect
sarscov
n
antigen
may
hold
signific
valu
sar
diagnosi
sever
acut
respiratori
syndrom
sar
recent
recogn
febril
respiratori
ill
first
appear
southern
china
novemb
sinc
spread
sever
countri
diseas
caus
novel
coronaviru
provision
name
sarsassoci
coronaviru
sarscov
drosten
et
al
ksiazek
et
al
peiri
et
al
sever
diseas
mortal
rate
appear
diagnost
method
sar
urgent
need
lipsitch
et
al
riley
et
al
sarscov
envelop
viru
posit
singlestrand
rna
genom
kb
length
open
read
frame
genom
organ
similar
coronaviru
phylogen
analys
sequenc
comparison
show
sarscov
close
relat
previous
character
coronaviru
marra
et
al
rota
et
al
structur
protein
gene
sarscov
contain
four
major
open
read
frame
includ
surfac
spike
glycoprotein
small
membran
protein
envelop
e
glycoprotein
nucleocapsid
n
protein
set
accessori
protein
whose
number
sequenc
vari
among
differ
coronavirus
siddel
n
protein
shown
strong
immunogen
sever
coronavirus
murin
coronaviru
wage
et
al
turkey
coronaviru
akin
et
al
porcin
reproduct
respiratori
syndrom
coronaviru
casal
et
al
report
n
protein
accumul
intracellularli
even
pack
matur
viru
collisson
et
al
abund
viru
derivedprotein
throughout
infect
probabl
templat
mrna
abund
subgenom
rna
hiscox
et
al
keck
et
al
featur
make
suitabl
candid
rais
antibodi
diagnost
applic
studi
sarscov
n
protein
gene
clone
sequenc
express
escherichia
coli
strain
purifi
homogen
use
purifi
n
protein
antigen
sar
diagnosi
compar
commerci
avail
detect
kit
coat
mixtur
sar
viral
protein
demonstr
antibodi
n
protein
high
sensit
specif
sar
diagnosi
serum
sampl
sarscov
infect
patient
clinic
diagnost
sar
follow
clinic
descript
sar
releas
hubei
beij
henan
collect
day
diseas
onset
one
hundr
thirtyon
serum
sampl
symptom
free
direct
contact
patient
physician
nurs
famili
member
nonsar
patient
show
symptom
fever
c
cough
sore
throat
collect
control
dr
zuojiong
gong
renmin
hospit
wuhan
univers
wuhan
china
cell
maintain
minim
essenti
medium
gibco
fetal
bovin
serum
hyclon
lglutamin
penicillin
streptomycin
c
humidifi
atmospher
viru
isol
perform
nasopharyng
swab
specimen
fatal
sar
case
belong
origin
case
cluster
wuhan
hubei
provinc
china
inocul
cell
viral
particl
purifi
centrifug
genet
materi
rna
extract
trizol
reagent
invitrogen
accord
manufactur
instruct
cdna
made
ad
l
extract
viral
rna
l
total
reaction
mixtur
use
amvrevers
transcriptas
kit
takara
biomed
japan
contain
random
primer
viral
cdna
use
templat
pcr
ad
l
l
total
reaction
mixtur
contain
transcript
buffer
mm
mgcl
mm
dntp
pmol
primer
u
lataq
tm
dna
polymeras
takara
biomed
japan
primer
synthes
accord
access
number
ie
forward
agctggatccatgtctgataatggaccccaatcaaac
revers
agctgaattccatcatgagtgtttatgcctgagt
product
amplifi
use
follow
condit
c
min
cycl
c
c
c
min
follow
one
cycl
c
min
examin
agaros
gel
electrophoresi
n
protein
gene
cdna
clone
pgem
easi
vector
promega
uk
standard
techniqu
transform
e
coli
strain
construct
pgemtnp
digest
bamhi
ecori
mbi
fermenta
germani
subclon
pethi
express
vector
therebi
introduc
small
tag
nterminu
protein
facilit
subsequ
purif
recombin
plasmid
transform
stain
seven
posit
coloni
analyz
confirm
pcr
sequenc
pethisn
plasmid
transform
e
coli
strain
protein
express
induc
addit
mmoll
iptg
cell
harvest
centrifug
pellet
suspend
bind
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
mm
naf
mm
pmsf
sonic
centrifug
g
c
min
clear
supernat
appli
ninta
affin
column
qiagen
wash
gradient
wash
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
purifi
n
protein
elut
elut
buffer
mm
trishcl
ph
mm
nacl
mm
imidazol
concentr
dialysi
polyethyleneglycol
fifti
nanogram
purifi
n
protein
dissolv
coat
buffer
na
co
nahco
ph
ad
micropl
incub
c
overnight
well
block
nonfat
milk
bsa
phosphat
buffer
salin
pb
incub
h
rt
wash
pb
dri
c
h
detect
chemiluminesc
method
sera
dilut
sampl
buffer
incub
c
min
well
wash
incub
peroxidaseconjug
rabbit
antihuman
antibodi
c
min
well
wash
pb
contain
peroxidas
reaction
visual
use
ophenylenediamin
substrat
min
c
reaction
stop
ad
lwell
h
absorb
read
nm
serum
sampl
run
triplic
cutoff
valu
defin
mean
od
control
sampl
plu
two
standard
deviat
sd
result
n
protein
elisa
compar
result
commerci
avail
elisa
kit
base
viral
n
e
protein
prepar
beij
genom
institut
chines
academi
scienc
beij
china
nucleocapsid
protein
gene
sequenc
sarscovhb
perform
sequenc
nt
deposit
gene
bank
access
number
full
length
n
protein
amino
acid
amino
termin
hexahistidinetag
express
purifi
ninta
affin
column
h
induct
serum
sampl
symptom
free
direct
contact
patient
physician
nurs
famili
member
nonsar
patient
show
symptom
fever
c
cough
sore
throat
iptg
high
level
express
n
protein
observ
fig
lane
compar
uninduc
cell
lysat
fig
lane
histag
protein
purifi
solubl
fraction
result
singl
band
expect
mass
kda
fig
lane
data
demonstr
sarscov
n
protein
success
express
e
coli
purifi
homogen
n
protein
identifi
western
blot
use
human
sarscov
infect
serum
data
shown
investig
immunoreact
nucleocapsid
protein
sarscov
infect
patient
sera
collect
day
diseas
onset
elisa
assay
establish
use
purifi
recombin
n
protein
interestingli
found
sar
patient
signific
posit
respons
n
protein
day
diseas
onset
respect
compar
result
commerci
avail
detect
elisa
kit
coat
mixtur
viral
protein
n
e
prepar
beij
genom
institut
chines
academi
scienc
beij
china
observ
immunoreact
sar
patient
antibodi
day
diseas
onset
respect
none
control
sera
symptom
free
nonsar
patient
gave
posit
reaction
either
assay
tabl
result
show
igg
antibodi
n
protein
commonli
present
sar
patient
sera
could
detect
earli
day
diseas
onset
mean
od
sd
obtain
use
control
sera
n
protein
coat
elisa
commerci
avail
detect
kit
respect
despit
initi
rapid
progress
discoveri
caus
agent
earli
develop
diagnost
test
critic
clinic
need
laboratori
test
confirm
diagnosi
sarscov
infect
earli
stage
real
time
rtpcr
optim
rna
extract
method
could
detect
nasopharyng
aspir
sampl
confirm
sar
patient
first
day
diseas
onset
howev
compar
improv
serolog
method
need
use
purifi
n
protein
antigen
elisa
assay
studi
sensit
specif
serodiagnosi
sar
result
indic
elisa
base
sarscov
n
protein
high
sensit
high
specif
eightyon
percent
sar
patient
posit
result
day
diseas
onset
posit
result
day
postinfect
compar
result
commerci
avail
diagnosi
kit
use
mixtur
viral
protein
sera
posit
day
diseas
onset
posit
day
respect
reactiv
observ
control
sampl
either
assay
differ
posit
respons
two
assay
may
due
quantiti
coat
n
protein
express
purif
procedur
use
recombin
viral
protein
work
suggest
high
specif
sensit
nucleocapsid
protein
elisa
indic
potenti
use
option
serodiagnosi
sar
particularli
laboratori
lack
bsl
facil
howev
cross
reactiv
assay
patient
recent
infect
human
coronavirus
requir
studi
close
therefor
experi
accumul
assay
suggest
nucleocapsid
protein
elisa
use
screen
test
posit
result
confirm
immunofluoresc
viru
neutral
test
